DK1409525T3 - Humant papillomavirus-E2-transaktiveringsdomæne/inhibitor-co-krystal og röntgenkoordinater, der definerer den inhibitorbindende lomme - Google Patents
Humant papillomavirus-E2-transaktiveringsdomæne/inhibitor-co-krystal og röntgenkoordinater, der definerer den inhibitorbindende lommeInfo
- Publication number
- DK1409525T3 DK1409525T3 DK02745024T DK02745024T DK1409525T3 DK 1409525 T3 DK1409525 T3 DK 1409525T3 DK 02745024 T DK02745024 T DK 02745024T DK 02745024 T DK02745024 T DK 02745024T DK 1409525 T3 DK1409525 T3 DK 1409525T3
- Authority
- DK
- Denmark
- Prior art keywords
- tad
- inhibitor
- hpv
- complex
- binding pocket
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 7
- 239000013078 crystal Substances 0.000 title abstract 2
- 101000742658 Human papillomavirus type 1 Regulatory protein E2 Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 title 1
- 239000000872 buffer Substances 0.000 abstract 2
- 239000011548 crystallization buffer Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000002156 mixing Methods 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Laminated Bodies (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30441201P | 2001-07-12 | 2001-07-12 | |
| PCT/CA2002/001058 WO2003006495A2 (en) | 2001-07-12 | 2002-07-12 | Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1409525T3 true DK1409525T3 (da) | 2007-02-05 |
Family
ID=23176405
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06012247.0T DK1695980T3 (da) | 2001-07-12 | 2002-07-12 | Co-krystal af human papillomavirus E2 transaktiveringsdomæne/inhibitor og røntgenkoordinater, der definerer inhibitor-bindingslommen |
| DK02745024T DK1409525T3 (da) | 2001-07-12 | 2002-07-12 | Humant papillomavirus-E2-transaktiveringsdomæne/inhibitor-co-krystal og röntgenkoordinater, der definerer den inhibitorbindende lomme |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06012247.0T DK1695980T3 (da) | 2001-07-12 | 2002-07-12 | Co-krystal af human papillomavirus E2 transaktiveringsdomæne/inhibitor og røntgenkoordinater, der definerer inhibitor-bindingslommen |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7167801B2 (da) |
| EP (2) | EP1695980B1 (da) |
| JP (1) | JP4602665B2 (da) |
| AT (2) | ATE343588T1 (da) |
| AU (1) | AU2002317122B2 (da) |
| CA (1) | CA2448482C (da) |
| DE (2) | DE60215658T2 (da) |
| DK (2) | DK1695980T3 (da) |
| ES (2) | ES2274051T3 (da) |
| HU (1) | HUP0402069A3 (da) |
| IL (2) | IL159150A0 (da) |
| MX (1) | MXPA04000271A (da) |
| NZ (1) | NZ531068A (da) |
| WO (1) | WO2003006495A2 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1627323A4 (en) * | 2003-05-06 | 2008-04-09 | New Century Pharmaceuticals | ALBUMIN FIXATION SITES FOR EVALUATING DRUG INTERACTIONS OR THE DEVELOPMENT OF MEDICAMENTS BASED ON THEIR ALBUMIN BINDING PROPERTIES |
| JP2007509605A (ja) * | 2003-05-26 | 2007-04-19 | バイオティ セラピーズ コーポレイション | 結晶性タンパク質ｖａｐ−１その用途 |
| CA2585115A1 (en) * | 2003-11-03 | 2005-05-12 | New Century Pharmaceuticals, Inc. | Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties |
| US20090118301A1 (en) * | 2007-11-02 | 2009-05-07 | Arbor Vita Corporation | Compositions and Methods for Treating Cancer |
| CN112891520A (zh) * | 2021-04-13 | 2021-06-04 | 吉林省国大生物工程有限公司 | 一种预防和控制人乳头瘤病毒感染（hpv）的活性生物蛋白的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU671808B2 (en) | 1991-10-11 | 1996-09-12 | Chiron Corporation | Methods and compositions for identifying inhibitors of papilloma virus replication |
| NZ508519A (en) | 1998-05-01 | 2003-12-19 | Boehringer Ingelheim Ca Ltd | Preparation of human papillomavirus E1 having helicase activity and method therefor |
| ATE235509T1 (de) | 1998-06-30 | 2003-04-15 | Deutsches Krebsforsch | Peptide zur inhibition von hpv e7 proteinen |
| WO2000075182A1 (fr) * | 1999-06-04 | 2000-12-14 | Akira Kaji | Cristal de proteine du facteur de recyclage ribosomique (rrf) et son application sur la base de donnees de structure tridimensionnelles provenant du cristal |
| GB9921938D0 (en) | 1999-09-17 | 1999-11-17 | Univ York | Target for antiviral therapy |
| EP1232253A2 (en) * | 1999-11-16 | 2002-08-21 | Vertex Pharmaceuticals Incorporated | Crystallizable compositions comprising a caspase-7 |
| EP1345943B1 (en) | 2000-12-18 | 2007-03-21 | Boehringer Ingelheim (Canada) Ltd. | Inhibitors of papilloma virus |
-
2002
- 2002-07-11 US US10/193,460 patent/US7167801B2/en not_active Expired - Lifetime
- 2002-07-12 JP JP2003512265A patent/JP4602665B2/ja not_active Expired - Fee Related
- 2002-07-12 IL IL15915002A patent/IL159150A0/xx unknown
- 2002-07-12 DE DE60215658T patent/DE60215658T2/de not_active Expired - Lifetime
- 2002-07-12 EP EP06012247A patent/EP1695980B1/en not_active Expired - Lifetime
- 2002-07-12 HU HU0402069A patent/HUP0402069A3/hu unknown
- 2002-07-12 CA CA2448482A patent/CA2448482C/en not_active Expired - Fee Related
- 2002-07-12 AU AU2002317122A patent/AU2002317122B2/en not_active Ceased
- 2002-07-12 NZ NZ531068A patent/NZ531068A/en not_active IP Right Cessation
- 2002-07-12 DK DK06012247.0T patent/DK1695980T3/da active
- 2002-07-12 AT AT02745024T patent/ATE343588T1/de active
- 2002-07-12 ES ES02745024T patent/ES2274051T3/es not_active Expired - Lifetime
- 2002-07-12 DK DK02745024T patent/DK1409525T3/da active
- 2002-07-12 EP EP02745024A patent/EP1409525B1/en not_active Expired - Lifetime
- 2002-07-12 DE DE60236114T patent/DE60236114D1/de not_active Expired - Lifetime
- 2002-07-12 ES ES06012247T patent/ES2342309T3/es not_active Expired - Lifetime
- 2002-07-12 WO PCT/CA2002/001058 patent/WO2003006495A2/en active IP Right Grant
- 2002-07-12 MX MXPA04000271A patent/MXPA04000271A/es active IP Right Grant
- 2002-07-12 AT AT06012247T patent/ATE465414T1/de active
-
2003
- 2003-12-02 IL IL159150A patent/IL159150A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003006495A2 (en) | 2003-01-23 |
| CA2448482C (en) | 2011-12-06 |
| DK1695980T3 (da) | 2010-08-02 |
| ES2274051T3 (es) | 2007-05-16 |
| EP1409525B1 (en) | 2006-10-25 |
| DE60215658T2 (de) | 2007-12-27 |
| IL159150A0 (en) | 2004-06-01 |
| EP1409525A2 (en) | 2004-04-21 |
| DE60236114D1 (de) | 2010-06-02 |
| DE60215658D1 (de) | 2006-12-07 |
| NZ531068A (en) | 2006-06-30 |
| US20030082769A1 (en) | 2003-05-01 |
| ATE343588T1 (de) | 2006-11-15 |
| ES2342309T3 (es) | 2010-07-05 |
| EP1695980A2 (en) | 2006-08-30 |
| JP4602665B2 (ja) | 2010-12-22 |
| CA2448482A1 (en) | 2003-01-23 |
| HUP0402069A3 (en) | 2012-09-28 |
| WO2003006495A3 (en) | 2003-07-31 |
| AU2002317122B2 (en) | 2007-03-15 |
| IL159150A (en) | 2009-09-01 |
| ATE465414T1 (de) | 2010-05-15 |
| HUP0402069A2 (hu) | 2005-01-28 |
| EP1695980A3 (en) | 2006-09-06 |
| US7167801B2 (en) | 2007-01-23 |
| MXPA04000271A (es) | 2005-03-07 |
| JP2005512954A (ja) | 2005-05-12 |
| EP1695980B1 (en) | 2010-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE413411T1 (de) | Substituierte cycloalkyl p1' hepatitis c virus inhibitoren | |
| ATE503764T1 (de) | Inhibitoren des hepatitis-c-virus | |
| DE50312257D1 (de) | (meth)acrylsaeurekristall und verfahren zur herstellung und aufreinigung von waessriger (meth)acrylsaeure | |
| EA200400183A1 (ru) | Кристаллы, содержащие соль n-[2-(диэтиламино)этил]-5-[(5-фторо-2-оксо-1,2-дигидро-3h-индол-3-илиден)метил]-2,4-диметил-1h-пиррол-3-карбоксамида с яблочной кислотой, способы их получения и их композиции | |
| NO20050741L (no) | Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den | |
| AU2003248535A1 (en) | Heterocyclicsulfonamide hepatitis c virus inhibitors | |
| FI970317A (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
| ATE431340T1 (de) | N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1- piperidincarboxamid-derivate und verwandte verbindungen als cgrp-antagonisten zur behandlung von kopfschmerzen | |
| CY1106721T1 (el) | Μεθοδος παρασκευης υψηλης καθαροτητας περινδοπριλης και ενδιαμεσα χρησιμα στη συνθεση | |
| ATE396190T1 (de) | Substituierte heteroarylalkansäure und ihre verwendung als inhibitoren der aldose reductase | |
| DE69719755D1 (de) | Polymorphe verbindungen | |
| DE50004569D1 (de) | Verfahren zur gewinnung von phytosterinen durch kristallisation aus verminderten mengen methanols | |
| DK1409525T3 (da) | Humant papillomavirus-E2-transaktiveringsdomæne/inhibitor-co-krystal og röntgenkoordinater, der definerer den inhibitorbindende lomme | |
| DE60113243D1 (de) | Neue kristalline form eines pyrrolidylthiocarbapenem-derivates | |
| ATE274513T1 (de) | Verbindungen und verfahren zur behandlung von schmerz | |
| ATE346029T1 (de) | 3,3,4,4-tetrafluorcyclopentanverbindungen als komponenten flüssigkristalliner medien | |
| TR200503397T1 (tr) | Levetirasetam'ın yeni kristal formları. | |
| ATE358675T1 (de) | Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol | |
| TR200503398T1 (tr) | Trandolapril'in yeni kristal formları. | |
| DK0691986T3 (da) | Hidtil ukendte fremgangsmåder og mellemproduktforbindelser til fremstillingen af blodpladeglycoprotein IIb/IIIa-inhibitorer | |
| SE9902147D0 (sv) | Nya föreningar och farmaceutiska kompositioner innehållande desamma | |
| TH57580B (th) | วิธีการผลิตผลึก | |
| RU95105969A (ru) | Производные диоксциклобутена, способ получения, фармацевтическая композиция, способ лечения гипертонии |